These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15710256)

  • 1. [Thrombophilias and vascular placental pathology. A survey of the literature].
    Verspyck E; Marpeau L
    Rev Med Interne; 2005 Feb; 26(2):103-8. PubMed ID: 15710256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticoagulation and antiaggregation during pregnancy].
    Biasiutti FD; Strebel JK
    Ther Umsch; 2003 Jan; 60(1):54-8. PubMed ID: 12638480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombophilia and adverse maternal-perinatal outcome: controversies in screening and management.
    Stella CL; How HY; Sibai BM
    Am J Perinatol; 2006 Nov; 23(8):499-506. PubMed ID: 17094039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventing adverse obstetric outcome in women with thrombophilia].
    Verspyck E
    Ann Med Interne (Paris); 2003; 154(5-6):366-9. PubMed ID: 15027592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome.
    Paidas MJ; Ku DH; Arkel YS
    Clin Perinatol; 2004 Dec; 31(4):783-805, vii. PubMed ID: 15519428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients?
    Rodger MA
    Thromb Res; 2013 Jan; 131 Suppl 1():S25-7. PubMed ID: 23452735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta.
    Arias F; Romero R; Joist H; Kraus FT
    J Matern Fetal Med; 1998; 7(6):277-86. PubMed ID: 9848693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse pregnancy outcome, the uteroplacental interface, and preventive strategies.
    Hossain N; Paidas MJ
    Semin Perinatol; 2007 Aug; 31(4):208-12. PubMed ID: 17825674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
    Fischer-Betz R; Specker C; Brinks R; Schneider M
    Lupus; 2012 Oct; 21(11):1183-9. PubMed ID: 22685017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding and Preventing Placenta-Mediated Pregnancy Complications.
    Skeith L; Blondon M; Ní Áinle F
    Hamostaseologie; 2020 Aug; 40(3):356-363. PubMed ID: 32726830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
    Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is thrombophilia a risk factor for placental vascular disorders?].
    Borg JY
    Ann Med Interne (Paris); 2003; 154(5-6):325-31. PubMed ID: 15027586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis and treatment of thrombophilia in pregnancy.
    Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
    Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pregnancy and antiphospholipid syndrome].
    Costedoat-Chalumeau N; Guettrot-Imbert G; Leguern V; Leroux G; Le Thi Huong D; Wechsler B; Morel N; Vauthier-Brouzes D; Dommergues M; Cornet A; Aumaître O; Pourrat O; Piette JC; Nizard J
    Rev Med Interne; 2012 Apr; 33(4):209-16. PubMed ID: 22341691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited and acquired thrombophilias.
    Rambaldi MP; Mecacci F; Guaschino S; Paidas MJ
    Reprod Sci; 2014 Feb; 21(2):167-82. PubMed ID: 23899550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary thrombophilias and placental-mediated pregnancy complications in the II./III. trimester].
    Rath W; Thaler CJ
    Hamostaseologie; 2013; 33(1):21-36. PubMed ID: 23392307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia.
    Leduc L; Dubois E; Takser L; Rey E; David M
    J Obstet Gynaecol Can; 2007 Oct; 29(10):787-93. PubMed ID: 17915061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.